Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07397143

Biomechanical Simulation Analysis of the Lower Extremity During Running in Males With Type A Lower Crossed Syndrome.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
Universiti Sains Malaysia · Academic / Other
Sex
Male
Age
18 Years – 25 Years
Healthy volunteers
Not accepted

Summary

This study aims to examine the effects of an 8-week exercise program on male patients with lower crossed syndrome type A. Participants are randomly assigned to either an exercise group or a control group. The exercise group takes part in a supervised kettlebell-based exercise program three times per week for eight weeks, while the control group receives usual care without the exercise program. Measurements are taken before and after the intervention to compare changes between the two groups.

Detailed description

This randomized controlled study investigates the effects of an exercise intervention on male patients with lower crossed syndrome type A. Participants who meet the eligibility criteria are randomly assigned to either an exercise intervention group or a control group. The intervention group performs a structured kettlebell-based exercise program three times per week for a duration of eight weeks, while the control group receives usual care without participation in the exercise program. Outcome measures are collected at baseline and after completion of the intervention period to evaluate changes associated with the exercise program.

Conditions

Interventions

TypeNameDescription
OTHERKettlebell Exercise ProgramA structured, supervised kettlebell-based exercise program performed three times per week for eight weeks. Each session lasts approximately 40 minutes and includes warm-up, kettlebell exercises targeting core and lower limb muscles, and cool-down. The program is designed to improve muscle balance and postural control in male patients with Type A Lower Crossed Syndrome .

Timeline

Start date
2025-10-10
Primary completion
2026-12-31
Completion
2027-12-31
First posted
2026-02-09
Last updated
2026-02-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07397143. Inclusion in this directory is not an endorsement.